Aeon
Connecting Sign in

Every public trading filing, minutes after it lands, in plain words.

Get alerts

← Feed

ACAD

ACADIA PHARMACEUTICALS INC

Alert me on ACAD
0
Insider buys, 6 months
0
Congress trades, 6 months
0
Signals, 6 months

Six months

After each filing

1
Sep 4, 2025 Sale GAROFALO ELIZABETH A. Insider
1 week
−5.1%S&P +1.3%
1 month
−14.5%S&P +3.4%
3 months
+1.5%S&P +5.6%
6 months
−13.1%S&P +4.2%

Every purchase and sale on this ticker reported by a member of Congress or an insider, measured from the close of the first trading day after it became public to the close 1 week, 1 month, 3 months and 6 months later, each beside the S&P over the same days.

Filings for ACAD 1 held · newest first
Loading the filings.

Government contracts, last 12 months

Awards of $10M and up, from USAspending · context, not a signal
No contracts of $10M or more in the last 12 months.

Lobbying

Last four quarters
$750KQ3 2025
$590KQ4 2025
$600KQ1 2026
$700KQ2 2026
Up 17 percent from Q1 2026. Reported by the company to the Senate each quarter.Original report ↗

Read from LDA.gov on Sep 23, 2026. Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.